In this issue:
Caspofungin vs fluconazole prophylaxis in adolescent AML
Gilteritinib or chemo for R/R FLT3-mutated AML
CD19 CAR T-cells for testicular relapse of B-cell ALL
Transplant in R/R ALL treated with blinatumomab
Outcomes for elderly AML after ICU admission
Nivolumab plus brentuximab vedotin for R/R PMBL
PET–guided treatment in early-stage favourable Hodgkin lymphoma
Ibrutinib plus venetoclax in R/R CLL
Time-to-progression after frontline FCR chemoimmunotherapy for CLL
Impact of concurrent indolent lymphoma on newly diagnosed DLBC
Please login below to download this issue (PDF)